Putting Strider in the pen is a terrible, terrible strategy.for his development. Dude is a SP and needs consistent work doing that.
While we have a ton of options at SP, none of them are proven. So relying on 2 of 5 rotation spots with unproven pitchers is an unwise decision too. Especially considering Morton's injury. We should approach this off-season with the understanding that we probably won't start the year with Morton and Soroka in the rotation. Honestly, anything we get from Soroka is gravy at this point. A reliable veteran SP will be needed. Greinke would be my preference depending on cost.
jpx7 (11-05-2021)
Yes I do believe players have a solid chance of being starting caliber CFers, though not at the start of the 2022 season. One bad season after a lost pandemic year doesn't change my opinion on either player. Both players have excellent skill sets. It won't take much for either player to be a starting caliber CFer.
The cost of Grienke for me will be prohibitive relative to the excess value he can provide to what is already on the roster for basically free.
Spend money on the best/cost effective 1b/DH/LF trio.
We have so much pitching that can get us through a regular season assuming the offense is what it can be with some additions.
Then come postseason we have a great top 3 with a strong bullpen for game 4 that is supported by an elite offense.
Natural Immunity Croc
Has anyone actually looked at the year Greinke had last season?
Tapate50 (11-05-2021)
Went back and did some quick comparison from Greinke vs Smyly
Greinke : 1.2 WAR, 171 IP, 1.17 WHIP, 4.16 ERA, 29 GS, 4.71 FIP
Smyly: 0.4 WAR, 126.2 IP, 1.374 WHIP, 4.48 ERA, 23 GS, 5.11 FIP
Get off my lawn!
jpx7 (11-05-2021), PawPawMaxwell (11-05-2021)
Lexicographers assemble! I think there needs to be a new word in the dictionary to describe how bad Pache was during his stint in the big leagues in 2021. I'm not going to put him in his baseball grave, but I'm not counting on him for 2022. Presence of the DH can cover some things, but it can't cover the level of performance we saw in 2021. Curious to see what type of CF insurance is in place as the 2022 team is assembled.
As I posted yesterday, Strider has less than 100 innings as a professional pitcher and he pitched very little in 2020 because of the truncated college season and the fact there was no minor league season. His stuff looked great in the lower minors, but he got beat up a little bit in AA (which is to be expected for a guy in his first professional season). I think we need to pump the brakes a bit and let him develop on a reasonable schedule.
1. What's happened to Morton that would have him out at the beginning of the year? A 6-8 week recovery, right? If he's fully functional by Christmas, one would think he'd be available for Spring Training in February.
2. Morton, Fried and Anderson are a suitable big three for a playoff run. The last two spots in the rotation don't need to be filled by higher priced vets that can give a 4+ ERA and eat innings (the Braves got a 4.48 out of Smyly for $11 Million). Ynoa, Toussaint and Mueller gave the Braves similar results for peanuts. Moreover, in order to keep their window open as long as possible, the Braves need to find a way to replace Morton with an internal option at the end of this year. That allows them to spread his $20 million around on raises. From a talent perspective, I understand the best options to currently be a 4 man race between Soroka, Wright, Ynoa and Mueller. The Braves have to give these guys starts in ATL to see if they have a future in ATL. Putting money into a vet arm, would indicate they've already decided they don't. If that's the case, that's really disappointing.
NYCBrave (11-05-2021)
I'd be okay rolling with Soroka/Wright/Ynoa/Mueller/Touki/Newcomb mix for the 4 and 5 spots in the rotation for a little bit. But I do feel like it would be a spot we may need to address at the deadline. Look at the Dodgers. They had a stacked rotation, with few depth pieces. Come playoff time, they only had 2 or 3 guys ready to go.
Get off my lawn!